IDS and mucopolysaccharidosis type 2: A previous study reported that pharmacological chaperone Δ-unsaturated 2-sulfouronic acid-N-sulfoglucosamine (D2S0) improves the function of IDS in fibroblasts derived from MPS II patients46.